Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source

NCT02167958 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
MDS
Myelofibrosis
Lymphoma

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Mesna
RADIATION: Total Body Irradiation
OTHER: Hematopoietic stem cell infusion
DRUG: Tacrolimus
DRUG: Mycophenolate
DRUG: G-CSF

Sponsor

Rafic Farah, MD